Figure 2.
Progression free and overall survival for patients with chemosensitive disease (CR or PR to ICE).

Progression free and overall survival for patients with chemosensitive disease (CR or PR to ICE).

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal